Managing Risk in Nanotechnology: Topics in Governance, Assurance and Transfer (Innovation, Technology, and Knowledge Management)

Finbarr Murphy, Eamonn McAlea, Martin Mullins

ISBN 10: 3319323903 ISBN 13: 9783319323909
Edité par Springer, 2016
Ancien(s) ou d'occasion Couverture rigide

Vendeur BookHolders, Towson, MD, Etats-Unis Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Vendeur AbeBooks depuis 19 juin 2001


A propos de cet article

Description :

[ No Hassle 30 Day Returns ][ Ships Daily ] [ Underlining/Highlighting: NONE ] [ Writing: NONE ] [ Edition: First ] Publisher: Springer Pub Date: 6/22/2016 Binding: hardcover Pages: 237 First edition. N° de réf. du vendeur 6942391

Signaler cet article

Synopsis :

This book aims to address how nanotechnology risks are being addressed by scientists, particularly in the areas of human health and the environment and how these risks can be measured in financial terms for insurers and regulators. It provides a comprehensive overview of nanotechnology risk measurement and risk transfer methods, including a chapter outlining how Bayesian methods can be used. It also examines nanotechnology from a legal perspective, both current and potential future outcomes.

The global market for nanotechnology products was valued at $22.9 billion in 2013 and increased to about $26 billion in 2014. This market is expected to reach about $64.2 billion by 2019, a compound annual growth rate (CAGR) of 19.8% from 2014 to 2019. Despite the increasing value of nanotechnologies and their widespread use, there is a significant gap between the enthusiasm of scientists and nanotechnology entrepreneurs working in the nanotechnology space and theinsurance/regulatory sector. Scientists are scarcely aware that insurers/regulators have concerns about the potential for human and environmental risk and insurers/regulators are not in a position to access the potential risk. This book aims to bridge this gap by defining the current challenges in nanotechnology across disciplines and providing a number of risk management and assessment methodologies.

Featuring contributions from authors in areas such as regulation, law, ethics, management, insurance and manufacturing, this volume provides an interdisciplinary perspective that is of value to students, academics, researchers, policy makers, practitioners and society in general.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Détails bibliographiques

Titre : Managing Risk in Nanotechnology: Topics in ...
Éditeur : Springer
Date d'édition : 2016
Reliure : Couverture rigide
Etat : Good

Meilleurs résultats de recherche sur AbeBooks

Image d'archives

Unbekannt
Edité par Springer, 2016
ISBN 10 : 3319323903 ISBN 13 : 9783319323909
Ancien ou d'occasion Couverture rigide

Vendeur : Buchpark, Trebbin, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | This book aims to address how nanotechnology risks are being addressed by scientists, particularly in the areas of human health and the environment and how these risks can be measured in financial terms for insurers and regulators. It provides a comprehensive overview of nanotechnology risk measurement and risk transfer methods, including a chapter outlining how Bayesian methods can be used. It also examines nanotechnology from a legal perspective, both current and potential future outcomes.The global market for nanotechnology products was valued at $22.9 billion in 2013 and increased to about $26 billion in 2014. This market is expected to reach about $64.2 billion by 2019, a compound annual growth rate (CAGR) of 19.8% from 2014 to 2019. Despite the increasing value of nanotechnologies and their widespread use, there is a significant gap between the enthusiasm of scientists and nanotechnology entrepreneurs working in the nanotechnology space and theinsurance/regulatory sector. Scientists are scarcely aware that insurers/regulators have concerns about the potential for human and environmental risk and insurers/regulators are not in a position to access the potential risk. This book aims to bridge this gap by defining the current challenges in nanotechnology across disciplines and providing a number of risk management and assessment methodologies.Featuring contributions from authors in areas such as regulation, law, ethics, management, insurance and manufacturing, this volume provides an interdisciplinary perspective that is of value to students, academics, researchers, policy makers, practitioners and society in general. N° de réf. du vendeur 26678681/2

Contacter le vendeur

Acheter D'occasion

EUR 71,33
Expédition à EUR 105
Expédition depuis Allemagne vers Etats-Unis

Quantité disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Murphy, Finbarr|McAlea, Eamonn M.|Mullins, Martin
ISBN 10 : 3319323903 ISBN 13 : 9783319323909
Neuf Couverture rigide
impression à la demande

Vendeur : moluna, Greven, Allemagne

Évaluation du vendeur 4 sur 5 étoiles Evaluation 4 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Examines how nanotechnology risks are being addressed by scientists and how these risks can be measured in financial termsProvides an overview of nanotechnology risk measurement and risk transferExplores ways in which insurance can impact . N° de réf. du vendeur 119052167

Contacter le vendeur

Acheter neuf

EUR 92,27
Expédition à EUR 48,99
Expédition depuis Allemagne vers Etats-Unis

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Edité par Springer, 2016
ISBN 10 : 3319323903 ISBN 13 : 9783319323909
Neuf Couverture rigide

Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. N° de réf. du vendeur ABLIING23Mar3113020093331

Contacter le vendeur

Acheter neuf

EUR 102,74
Expédition à EUR 3,42
Expédition nationale : Etats-Unis

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

Finbarr Murphy
ISBN 10 : 3319323903 ISBN 13 : 9783319323909
Neuf Couverture rigide

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This book aims to address how nanotechnology risks are being addressed by scientists, particularly in the areas of human health and the environment and how these risks can be measured in financial terms for insurers and regulators. It provides a comprehensive overview of nanotechnology risk measurement and risk transfer methods, including a chapter outlining how Bayesian methods can be used. It also examines nanotechnology from a legal perspective, both current and potential future outcomes.The global market for nanotechnology products was valued at $22.9 billion in 2013 and increased to about $26 billion in 2014. This market is expected to reach about $64.2 billion by 2019, a compound annual growth rate (CAGR) of 19.8% from 2014 to 2019. Despitetheincreasing value of nanotechnologies and their widespread use, there is a significant gap between the enthusiasm of scientists and nanotechnology entrepreneurs workinginthe nanotechnology space and theinsurance/regulatory sector. Scientists are scarcely aware that insurers/regulators have concerns about the potential for human and environmental risk and insurers/regulators are not in a position to access the potential risk.This book aims to bridge this gap by defining the current challenges in nanotechnology across disciplines and providing a number of risk management and assessment methodologies.Featuring contributions from authors in areas such as regulation, law, ethics, management, insurance and manufacturing, this volume provides an interdisciplinary perspective that is of value to students, academics, researchers, policy makers, practitioners and society in general. N° de réf. du vendeur 9783319323909

Contacter le vendeur

Acheter neuf

EUR 106,99
Expédition à EUR 62,74
Expédition depuis Allemagne vers Etats-Unis

Quantité disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Finbarr Murphy
ISBN 10 : 3319323903 ISBN 13 : 9783319323909
Neuf Couverture rigide
impression à la demande

Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book aims to address how nanotechnology risks are being addressed by scientists, particularly in the areas of human health and the environment and how these risks can be measured in financial terms for insurers and regulators. It provides a comprehensive overview of nanotechnology risk measurement and risk transfer methods, including a chapter outlining how Bayesian methods can be used. It also examines nanotechnology from a legal perspective, both current and potential future outcomes.The global market for nanotechnology products was valued at $22.9 billion in 2013 and increased to about $26 billion in 2014. This market is expected to reach about $64.2 billion by 2019, a compound annual growth rate (CAGR) of 19.8% from 2014 to 2019. Despitetheincreasing value of nanotechnologies and their widespread use, there is a significant gap between the enthusiasm of scientists and nanotechnology entrepreneurs workinginthe nanotechnology space and the insurance/regulatory sector. Scientists are scarcely aware that insurers/regulators have concerns about the potential for human and environmental risk and insurers/regulators are not in a position to access the potential risk.This book aims to bridge this gap by defining the current challenges in nanotechnology across disciplines and providing a number of risk management and assessment methodologies.Featuring contributions from authors in areas such as regulation, law, ethics, management, insurance and manufacturing, this volume provides an interdisciplinary perspective that is of value to students, academics, researchers, policy makers, practitioners and society in general. 252 pp. Englisch. N° de réf. du vendeur 9783319323909

Contacter le vendeur

Acheter neuf

EUR 106,99
Expédition à EUR 23
Expédition depuis Allemagne vers Etats-Unis

Quantité disponible : 2 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Finbarr Murphy
ISBN 10 : 3319323903 ISBN 13 : 9783319323909
Neuf Couverture rigide

Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Buch. Etat : Neu. Neuware -This book aims to address how nanotechnology risks are being addressed by scientists, particularly in the areas of human health and the environment and how these risks can be measured in financial terms for insurers and regulators. It provides a comprehensive overview of nanotechnology risk measurement and risk transfer methods, including a chapter outlining how Bayesian methods can be used. It also examines nanotechnology from a legal perspective, both current and potential future outcomes.The global market for nanotechnology products was valued at $22.9 billion in 2013 and increased to about $26 billion in 2014. This market is expected to reach about $64.2 billion by 2019, a compound annual growth rate (CAGR) of 19.8% from 2014 to 2019. Despite the increasing value of nanotechnologies and their widespread use, there is a significant gap between the enthusiasm of scientists and nanotechnology entrepreneurs working in the nanotechnology space and theinsurance/regulatory sector. Scientists are scarcely aware that insurers/regulators have concerns about the potential for human and environmental risk and insurers/regulators are not in a position to access the potential risk. This book aims to bridge this gap by defining the current challenges in nanotechnology across disciplines and providing a number of risk management and assessment methodologies.Featuring contributions from authors in areas such as regulation, law, ethics, management, insurance and manufacturing, this volume provides an interdisciplinary perspective that is of value to students, academics, researchers, policy makers, practitioners and society in general.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 252 pp. Englisch. N° de réf. du vendeur 9783319323909

Contacter le vendeur

Acheter neuf

EUR 106,99
Expédition à EUR 60
Expédition depuis Allemagne vers Etats-Unis

Quantité disponible : 2 disponible(s)

Ajouter au panier

Image d'archives

Edité par Springer, 2016
ISBN 10 : 3319323903 ISBN 13 : 9783319323909
Neuf Couverture rigide

Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. In. N° de réf. du vendeur ria9783319323909_new

Contacter le vendeur

Acheter neuf

EUR 111,65
Expédition à EUR 13,77
Expédition depuis Royaume-Uni vers Etats-Unis

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Murphy, Finbarr (Edited by)/ McAlea, Eamonn M. (Edited by)/ Mullins, Martin (Edited by)
Edité par Springer, 2016
ISBN 10 : 3319323903 ISBN 13 : 9783319323909
Neuf Couverture rigide

Vendeur : Revaluation Books, Exeter, Royaume-Uni

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Hardcover. Etat : Brand New. 252 pages. 9.25x6.25x0.75 inches. In Stock. N° de réf. du vendeur x-3319323903

Contacter le vendeur

Acheter neuf

EUR 152,77
Expédition à EUR 40,23
Expédition depuis Royaume-Uni vers Etats-Unis

Quantité disponible : 2 disponible(s)

Ajouter au panier